The Future is Coming!
![](https://dupuytrens.org/wp-content/uploads/2023/05/2016_MassonMeyers-pdf-768x1024.jpg)
Improving the Future of Dupuytren Care Right now, many people with mild Dupuytren biology do well after surgery or after Xiaflex – because most people have mild to moderate Dupuytren biology. The issue isn’t the patient with mild disease biology who will do well for a long time after any treatment. The issue is those […]